New cymbalta contraindication

Duloxetine has been associated with an increase in blood pressure and cases of hypertensive crisis have been reported, especially in patients with pre-existing hypertension.

Therefore, Cymbalta (duloxetine hydrochloride) is now contraindicated in patients with uncontrolled hypertension. For patients who experience a sustained increase in blood pressure while receiving duloxetine, either a dose reduction or gradual discontinuation should be considered. In patients with known hypertension and/or other cardiac disease, blood pressure monitoring is recommended, especially during the first month of treatment.

Further information: Lilly 01256 315000

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Added: Efracea.
Use our constantly updated shortages...

Potentially addictive medicines 'being prescribed for years'

Potentially addictive medicines 'being prescribed for years'

Hundreds of thousands of people are receiving prescriptions...

Calcium and Vitamin D Supplements for Osteoporosis

Calcium and Vitamin D Supplements for Osteoporosis

Formulations, doses and costs of osteoporosis supplements.

High-dose statins could be made available over the counter, says NHS England

High-dose statins could be made available over the counter, says NHS England

High-dose statins could be supplied by pharmacists...